FCGR2B |
FCGR2B, CD32, FCG2, IGFR2: Low affinity immunoglobulin gamma Fc region receptor |
LYN |
LYN: Tyrosine-protein kinase Lyn |
9.925 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
9.925 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
CD79B |
CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p |
9.925 |
Evidence |
|
CD79B |
CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p |
SYK |
SYK: Tyrosine-protein kinase SYK |
9.925 |
Evidence |
|
JAK1 |
|
PTPRC |
PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ |
9.925 |
Evidence |
|
LAT |
LAT: Linker for activation of T-cells family member 1 |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
9.925 |
Evidence |
|
IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
9.925 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
PTPRC |
PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ |
9.925 |
Evidence |
|
PRKR |
EIF2AK2, PKR, PRKR: Interferon-induced, double-stranded RNA-activated protein ki |
STAT3 |
|
9.925 |
Evidence |
|
LAT |
LAT: Linker for activation of T-cells family member 1 |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
9.925 |
Evidence |
|
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
IL6ST |
IL6ST: Interleukin-6 receptor subunit beta precursor |
9.925 |
Evidence |
|
CD79B |
CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
9.925 |
Evidence |
|
CD247 |
CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
9.925 |
Evidence |
|
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
9.925 |
Evidence |
|
IL6ST |
IL6ST: Interleukin-6 receptor subunit beta precursor |
JAK1 |
|
9.925 |
Evidence |
|
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
STAT3 |
|
9.925 |
Evidence |
|
CD79B |
CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p |
LYN |
LYN: Tyrosine-protein kinase Lyn |
9.925 |
Evidence |
|
CD247 |
CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
9.925 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
IL6ST |
IL6ST: Interleukin-6 receptor subunit beta precursor |
9.925 |
Evidence |
|
IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
JAK1 |
|
9.925 |
Evidence |
|
SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
IRS1 |
IRS1: Insulin receptor substrate 1 |
9.897 |
Evidence |
O
|
PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
9.897 |
Evidence |
|
CFB |
CFB, BF, BFD: Complement factor B precursor |
CFP |
CFP, PFC: Properdin precursor |
9.897 |
Evidence |
|
IRS1 |
IRS1: Insulin receptor substrate 1 |
JAK1 |
|
9.897 |
Evidence |
|
MMP7 |
MMP7, MPSL1, PUMP1: Matrilysin precursor |
MMP9 |
MMP9, CLG4B: Matrix metalloproteinase-9 precursor |
9.897 |
Evidence |
|